Skip to main content

NOMO2 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and 1 bp insertion in exon 1 and 2 bp insertion in exon 1.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human NOMO2 knockout HeLa cell line (AB265218), expandable thumbnail
  • Sanger Sequencing - Human NOMO2 knockout HeLa cell line (AB265218), expandable thumbnail
  • Sanger Sequencing - Human NOMO2 knockout HeLa cell line (AB265218), expandable thumbnail

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and 1 bp insertion in exon 1 and 2 bp insertion in exon 1

Alternative names

Recommended products

NOMO2 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and 1 bp insertion in exon 1 and 2 bp insertion in exon 1.

Key facts

Cell type

HeLa

Form

Liquid

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and 1 bp insertion in exon 1 and 2 bp insertion in exon 1

Disease

Adenocarcinoma

Concentration
Loading...

Properties

Gene name

NOMO2

Gene editing type

Knockout

Gene editing method

CRISPR technology

Knockout validation

Sanger Sequencing

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines

  • All seeding densities should be based on cell counts gained by established methods.

  • A guide seeding density of 2x104 cells/cm2 is recommended.

  • Cells should be passaged when they have achieved 80-90% confluence.

Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Storage

Shipped at conditions

Dry Ice

Appropriate short-term storage conditions

-196°C

Appropriate long-term storage conditions

-196°C

Notes

Recommended control: Human wild-type HeLa cell line (Human wild-type HeLa cell line ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.

Activity summary

NOMO2 also known as Nodal Modulator 2 or pM5 is an endoplasmic reticulum membrane protein with a molecular mass of approximately 130 kDa. It functions mechanically as a part of the Nomo family which includes homologous proteins such as NOMO1 and NOMO3. The NOMO2 protein plays a critical role in the suppression of Nodal signaling. This protein is ubiquitously expressed but with higher levels observed in tissues including the pancreas and testis.

Biological function summary

NOMO2 modulates essential signaling pathways during early embryonic development. It acts as part of a larger protein complex known as the Nicalin-NOMO complex which modulates Nodal signaling. This signaling is important for pattern formation and axis specification during embryogenesis. By participating in these processes NOMO2 contributes to the regulation of cellular differentiation and proliferation.

Pathways

NOMO2 operates within the TGF-beta signaling pathway an important player in cell growth and differentiation. It directly influences Nodal signaling a branch of the TGF-beta pathway by interacting with other proteins like Nicalin and TMEM147. Through its involvement in these pathways NOMO2 helps coordinate cellular responses and genetic transcription important for embryonic patterning and organogenesis.

Associated diseases and disorders

NOMO2 is linked to congenital disorders resulting from disrupted embryonic development. Alterations in NOMO2 function can contribute to conditions such as congenital heart defects. Additionally NOMO2's connection with the TGF-beta pathway may influence cancer progression as this pathway frequently interacts with oncogenes and tumor suppressors like SMAD proteins that are dysregulated in cancer.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

3 product images

  • Sanger Sequencing - Human NOMO2 knockout HeLa cell line (ab265218), expandable thumbnail

    Sanger Sequencing - Human NOMO2 knockout HeLa cell line (ab265218)

    Allele-3: 2 bp insertion in exon 1.

  • Sanger Sequencing - Human NOMO2 knockout HeLa cell line (ab265218), expandable thumbnail

    Sanger Sequencing - Human NOMO2 knockout HeLa cell line (ab265218)

    Allele-2: 1 bp insertion in exon 1.

  • Sanger Sequencing - Human NOMO2 knockout HeLa cell line (ab265218), expandable thumbnail

    Sanger Sequencing - Human NOMO2 knockout HeLa cell line (ab265218)

    Allele-1: 1 bp deletion in exon 1.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com